Crabb I, Thornton C, Konieczko K M, Chan A, Aquilina R, Frazer N, Doré C J, Newton D E
Department of Anaesthesia, Northwick Park Hospital.
Br J Anaesth. 1996 Jun;76(6):795-801. doi: 10.1093/bja/76.6.795.
We studied 60 patients during stable isoflurane anaesthesia (0.4 MAC) after premedication with temazepam. Patients were allocated randomly to one of three dose regimens of remifentanil: 1 microgram kg-1 i.v. over 1 min and an infusion of 0.2 microgram kg-1 min-1 (low dose); 2.5 micrograms kg-1 and 0.5 microgram kg-1 min-1 (medium dose); and 5 micrograms kg-1 and 1 microgram kg-1 min-1 (high dose). The auditory (AER) and median nerve somatosensory (SER) responses were elicited throughout, and recorded before and after tracheal intubation, and surgical incision, together with systolic and diastolic arterial pressure and heart rate. Venous blood concentrations of remifentanil were measured at the above times. After administration of remifentanil, Pa and Nb amplitudes of the AER increased at the low dose, remained constant at the medium dose and decreased at the high dose. This dose-related effect was linear and significant (P = 0.012, P = 0.05). Pa amplitude correlated inversely with remifentanil blood concentrations before and after intubation and incision (P = 0.002, P < 0.001, P < 0.001 and P < 0.001). In the SER, P15-N20 amplitudes decreased after administration of remifentanil (P < 0.001), whereas P25-N35 and N35-P45 amplitudes increased at all dose concentrations (P < 0.001 and P < 0.001). After intubation, P15-N20 and N35-P45 amplitudes increased at the low dose, did not change at the medium dose and decreased at the high dose (P = 0.001, P = 0.027). After remifentanil, systolic and diastolic arterial pressure and heart rate decreased in a linearly dose-related manner (P = 0.033, P < 0.001, P < 0.001). At all doses the three variables increased after intubation (P = 0.001, P < 0.001, P < 0.01), and systolic and diastolic arterial pressure increased after incision (P = 0.027, P = 0.039).
我们对60例在接受替马西泮术前用药后处于异氟烷稳定麻醉状态(0.4MAC)的患者进行了研究。患者被随机分配至三种瑞芬太尼剂量方案之一:静脉注射1微克/千克,持续1分钟,随后以0.2微克/千克·分钟的速度输注(低剂量);2.5微克/千克和0.5微克/千克·分钟(中等剂量);以及5微克/千克和1微克/千克·分钟(高剂量)。在整个过程中诱发听觉诱发电位(AER)和正中神经体感诱发电位(SER),并在气管插管前、气管插管后、手术切口前和手术切口后进行记录,同时记录收缩压、舒张压和心率。在上述时间点测量瑞芬太尼的静脉血浓度。给予瑞芬太尼后,低剂量时AER的Pa和Nb波幅增加,中等剂量时保持不变,高剂量时降低。这种剂量相关效应呈线性且具有显著性(P = 0.012,P = 0.05)。插管和切口前后,Pa波幅与瑞芬太尼血药浓度呈负相关(P = 0.002,P < 0.001,P < 0.001和P < 0.001)。在SER中,给予瑞芬太尼后P15 - N20波幅降低(P < 0.001),而P25 - N35和N35 - P45波幅在所有剂量浓度下均增加(P < 0.001和P < 0.001)。插管后,低剂量时P15 - N20和N35 - P45波幅增加,中等剂量时无变化,高剂量时降低(P = 0.001,P = 0.027)。给予瑞芬太尼后,收缩压、舒张压和心率呈线性剂量相关下降(P = 0.033,P < 0.001,P < 0.001)。在所有剂量下,气管插管后这三个变量均增加(P = 0.001,P < 0.001,P < 0.01),手术切口后收缩压和舒张压升高(P = 0.027,P = 0.039)。